Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Clinical trial NCT06826092 · RECRUITING

Trial details

NCT number: NCT06826092
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Progression-Free Survival

Start date: 2022-10-31
Primary completion: 2025-12-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.